NKGen Biotech, Inc. (NKGN)
OTCMKTS · Delayed Price · Currency is USD
0.2400
-0.0100 (-4.00%)
Jul 18, 2025, 4:00 PM EDT
NKGen Biotech Market Cap
NKGen Biotech has a market cap or net worth of $17.94 million as of July 18, 2025. Its market cap has decreased by -40.43% in one year.
Market Cap
17.94M
Enterprise Value
48.67M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.24
Market Cap Chart
Since August 4, 2023, NKGen Biotech's market cap has decreased from 338.09M to 17.94M, a decrease of -94.69%. That is a compound annual growth rate of -77.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 18, 2025 | 17.94M | -23.98% |
| Dec 31, 2024 | 23.60M | -60.80% |
| Dec 29, 2023 | 60.19M | -82.20% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.62B |
| Veradigm | 832.17M |
| Nika Pharmaceuticals | 708.22M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 608.62M |
| Glass House Brands | 450.03M |
| CytoDyn | 394.89M |
| Northwest Biotherapeutics | 382.15M |